Gupta Suneel 4
4 · Protagonist Therapeutics, Inc · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Gupta Suneel
EVP Clinical Operations
Transactions
- Award
Stock Option (right to buy)
2024-01-02+71,500→ 71,500 totalExercise: $23.42Exp: 2034-01-02→ Common Stock (71,500 underlying) - Award
Common Stock
2024-01-02+19,250→ 187,567 total
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
- [F2]The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.